胫骨—软骨粘液样纤维瘤

2022-08-26 放射沙龙 南京医学会放射学分会

软骨粘液样纤维瘤影像学检查及鉴别诊断。

影像学检查


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1804065, encodeId=948e18040657e, content=<a href='/topic/show?id=dfabe625323' target=_blank style='color:#2F92EE;'>#粘液样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76253, encryptionId=dfabe625323, topicName=粘液样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon Aug 15 23:51:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387764, encodeId=0536138e764db, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412192, encodeId=2bec1412192ca, content=<a href='/topic/show?id=504a83820a0' target=_blank style='color:#2F92EE;'>#胫骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83820, encryptionId=504a83820a0, topicName=胫骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c442828835, createdName=yb6561, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1804065, encodeId=948e18040657e, content=<a href='/topic/show?id=dfabe625323' target=_blank style='color:#2F92EE;'>#粘液样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76253, encryptionId=dfabe625323, topicName=粘液样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon Aug 15 23:51:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387764, encodeId=0536138e764db, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412192, encodeId=2bec1412192ca, content=<a href='/topic/show?id=504a83820a0' target=_blank style='color:#2F92EE;'>#胫骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83820, encryptionId=504a83820a0, topicName=胫骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c442828835, createdName=yb6561, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1804065, encodeId=948e18040657e, content=<a href='/topic/show?id=dfabe625323' target=_blank style='color:#2F92EE;'>#粘液样#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76253, encryptionId=dfabe625323, topicName=粘液样)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon Aug 15 23:51:03 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387764, encodeId=0536138e764db, content=<a href='/topic/show?id=f210e72532e' target=_blank style='color:#2F92EE;'>#纤维瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77253, encryptionId=f210e72532e, topicName=纤维瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fc62500009, createdName=12498474m30暂无昵称, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412192, encodeId=2bec1412192ca, content=<a href='/topic/show?id=504a83820a0' target=_blank style='color:#2F92EE;'>#胫骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83820, encryptionId=504a83820a0, topicName=胫骨)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c442828835, createdName=yb6561, createdTime=Wed Nov 10 00:51:03 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-11-10 yb6561

相关资讯

Lancet Oncol:乐伐替尼+依托泊苷+异环磷酰胺,复发/难治性骨肉瘤的新联合治疗方案?

乐伐替尼与依托泊苷和异环磷酰胺的联合方案在复发性/难治性骨肉瘤患者中展现出了令人期待的抗肿瘤活性

Eur Radiol:用磁共振来评价骨肿瘤的化疗效果并评价生存期

在骨肉瘤中,化疗诱导的肿瘤坏死是公认的预后预测因素。经化疗后肿瘤坏死超过90%患者的生存率明显提高。因此,确立一种能够在手术切除前无创的预测肿瘤对新辅助化疗反应的方法十分有必要。

FDA授予IVT-8086治疗骨肉瘤罕见儿科疾病(RPD)称号

IVT-8086是一种人源化单克隆抗体(mAb),对新型抗癌靶标(SFRP2,分泌型卷曲相关蛋白2)具有高度亲和力。

女性,右小腿酸胀不适,请诊断!

女性,右小腿酸胀不适,请诊断!

Cell Death Dis:LncRNA KCNQ1OT1通过增强有氧糖酵解促进骨肉瘤进展

骨肉瘤(OS)是最具侵袭性和最常见的原发性恶性骨肿瘤之一,在儿童和青少年中最常见。 随着手术、化学疗法和放射性疗法等各种治疗手段的进步,非转移性OS患者的五年生存率已达到60%。 然而由于对OS的发病

Cancer Cell Int:与骨肉瘤微环境相关的免疫相关预后生物标记物

骨肉瘤是一种高侵袭性的骨肿瘤,多见于儿童和青少年。在过去30年里,骨肉瘤的治疗和结局一直没有改变。骨肉瘤与免疫微环境之间的关系可能是治疗骨肉瘤的关键。